Leija HC, Rojas SL, Flores MI, Becerril RR

Language: Spanish
References: 15
Page: 13-17
PDF size: 83.17 Kb.

ABSTRACT

The Endocarditis of the prosthetic valve (EVP) represents one complication serious in surgery change valvular that global frequency is 1-4%, mortality of 25-64%. In the Cardiology National Institute “Ignacio Chavez” (INCICH), the Control Infections Nosocomial Committee, to carry out keep epidemiology patients that present EVP, with evolution and treatment the patients. Objectives: Obtain incidence of EVP in the INCICH, to recognize relation factors with morbi-mortality. Material and methods: Was realize study descriptive, analytic, transversal and retrospective in period 1991 to 2002 of the valvular changes, to include the EVP episodes. Results: Identificaty 44 cases of EVP of 4,271 valvular changes, was obtained level incident 1%; the mitral valve more affect 47.7%, aortic 34% and combination aortic and mitral 9%; microorganisms isolated are S. epidermidis with 54.5%, S. aureus 20.4%, gramnegative germ 11.3%. The EVP was watched an 61.3% in mechanic prosthesis and 38.6% in the biologic. The early EVP of 63.6% and late 36.3%. Conclusions: In INCICH incidence EVP is low the accord with this publication, establishment measures for prevention infections nosocomials in periods trans and after of surgery change valvular; these influence in prevention directly in this event.

REFERENCES

1. Sánchez RA, Domínguez RMJ, Sánchez HA. Endocarditis infecciosa citado en: www.edu/tratado/c010703.html.

2. Howard RJ, Simons RL. Tratado de infecciones en cirugía. 2a ed. México; McGraw-Hill, 1991.

3. Griffin MR, Wilson WR, Edwards WD et al. Infective endocarditis-Olmstead. County, Minnesota, 1950 through 1981. JAMA 1985; 254: 1199.

4. Wolf M, Witchitz S. Infective Endocarditis. In: Pathophysiologic foundations of critical care. Pinsky MR et al (eds). Williams and Wilkins. Baltimore. 1993: 372-385.

5. Calderwood SB, Swinski LA, Waternaux CM et al. Risk factors for the development of prosthetic valve endocarditis. Circulation 1985; 72: 31.

6. Ortiz de Salazar A, Castellanos E, Aramendi JI, Llorente A, Agosti J. La endocarditis protésica. Un desafío actual en la cirugía de reemplazo valvular. Revista Latina de Cardiología 1993; 14(5): 166-170.

7. Jiménez FJ, Ruiz JM, Enero J. El ecocardiograma en el postoperatorio de cirugía cardíaca. En: Técnicas ecocardiográficas en medicina intensiva. Editorial MCR, SA. Barcelona. 1996: 69-82.

8. Kaye D. Endocarditis infecciosa. In: Harrison. Principios de Medicina Interna. (13ª ed). Isselbacher KJ et al (eds). Interamericana/McGraw-Hill. Madrid. 1994: 607-613.

9. Dajani AS, Taubeert KA, Wilson W et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation 1997; 96: 358-366.

10. Rodgers GM, Greenberg CS, Shuman MA. Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood 1983; 61: 1155.

11. Korzeniowski OM, Kaye D. Endocarditis infecciosa. En: Tratado de Cardiología. E. Branwal (ed). IV edición. McGraw-Hill. Interamericana de España. Madrid. 1993: 1207-1238.

12. Ferguson DJP, McColm AA, Savage TL et al. A morphologic study of study of experimental rabbit staphylococcal endocarditis and aortitis. II. Inter-relationship of bacteria, vegetation and cardiovasculature in established infections. Br J Exp Pathol 1986; 67: 679.

13. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30: 633-638.

14. Bayer AS, Bolger AF, Taubert KA et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998; 98: 2936-2948.

15. Casabé-Suárez-Torino. Las formas actuales de la endocarditis infecciosa. Buenos Aires. Ed. Panamericana; 2001.